乳房超音波市场机会、成长要素、产业趋势分析及2026年至2035年预测

全球乳房超音波市场预计到 2025 年将达到 35 亿美元，到 2035 年将达到 76 亿美元，年复合成长率为 8.3%。

全球乳癌负担日益加重、筛检意识不断提高、公共卫生政策支持以及超音波影像技术的持续创新，共同推动了市场成长。全球乳癌发生率的上升凸显了早期检测和精准诊断工具的重要性，直接增加了对乳房超音波系统的需求。这些系统因其非侵入性影像、无辐射暴露且适用于重复筛检和后续观察被广泛采用。不断扩大的宣传活动和支持性医疗政策提高了常规筛检的参与率，进一步增强了市场需求。对乳房健康的深入了解，以及诊断服务的日益普及，持续推动乳房超音波在医疗机构的应用。影像清晰度、自动化程度和诊断准确性的技术进步提高了临床可靠性，并促进了乳房超音波在标准诊断流程中的广泛应用。随着医疗系统日益重视早期诊断和患者安全，乳房超音波仍然是支撑市场长期成长的关键影像解决方案。

预计到2025年，自动化超音波市场规模将达到23亿美元，占市占率的65.1%。自动化乳房超音波技术透过标准化扫描提供全面的影像，从而实现一致的影像品质和乳房组织的精细可视化。减少对操作者的依赖性以及提高诊断信心，并持续推动自动化系统在临床应用中的普及。

医院仍将是乳房超音波检查的主要医疗场所，到 2024 年将占 45.6% 的市场份额。这些机构提供先进的影像设备和综合诊断服务，有助于在单一的医疗保健环境中进行准确的检测、评估和后续观察。

预计到2025年，北美乳腺超音波市场份额将达到34%。疾病盛行率上升、筛检检测普及率提高以及技术持续整合正在推动全部区域的需求成长。医疗机构越来越依赖先进的超音波解决方案来提高诊断准确性并减少解读差异。

目录

第一章调查方法和范围

第二章执行摘要

第三章业界考察

• 生态系分析
• 产业影响因素
  • 司机
    • 全球乳癌发生率不断上升
    • 乳房超音波诊断设备的技术进步
    • 对乳癌的认识提高以及政府的有利政策
    • 改善美国乳房超音波筛检的保险报销
  • 产业潜在风险与挑战
    • 自动乳房超音波设备高成本
    • 发展中和欠发达地区缺乏技术熟练或训练有素的劳动力
  • 市场机会
    • 与远端医疗的合作
• 成长潜力分析
• 监管环境
• 技术进步
  • 当前技术趋势
  • 新兴技术
• 2024年定价分析
• 未来市场趋势
• 波特五力分析
• PESTEL 分析

第四章 竞争情势

• 介绍
• 公司市占率分析
• 企业矩阵分析
• 主要市场公司的竞争分析
• 竞争定位矩阵
• 重大进展
  • 併购
  • 合作伙伴关係和合资企业
  • 新产品发布
  • 扩张计划

第五章 按类型分類的市场估算与预测，2022-2035年

• 常规超音波
• 自动超音波设备

6. 依最终用途分類的市场估计与预测，2022-2035 年

• 医院
• 诊断检查室
• 其他最终用户

第七章 2022-2035年各地区市场估算与预测

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿拉伯聯合大公国

第八章 公司简介

• CapeRay
• Delphinus Medical Technologies, Inc.
• GE Healthcare
• Koninklijke Philips NV
• Siemens Healthineers AG
• Canon Medical Systems Corporation
• Fukuda Denshi
• Hologic, Inc.
• Seno Medical Instruments Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Samsung Electronics Co. Ltd.
• FujiFilm Holdings Corporation

The Global Breast Ultrasound Market was valued at USD 3.5 billion in 2025 and is estimated to grow at a CAGR of 8.3% to reach USD 7.6 billion by 2035.

Market growth is supported by the rising global burden of breast cancer, increasing screening awareness, supportive public health initiatives, and continuous innovation in ultrasound imaging technologies. The growing incidence of breast cancer worldwide has intensified the need for early-stage detection and accurate diagnostic tools, directly increasing demand for breast ultrasound systems. These systems are widely adopted because they enable non-invasive imaging without radiation exposure, making them suitable for repeated screenings and follow-up evaluations. Expanded awareness programs and favorable healthcare policies have encouraged higher participation in routine screening, further strengthening market demand. Improved understanding of breast health, combined with broader access to diagnostic services, continues to drive adoption across healthcare settings. Technological improvements in image clarity, automation, and diagnostic accuracy are enhancing clinical confidence and supporting wider integration of breast ultrasound into standard diagnostic workflows. As healthcare systems place greater emphasis on early diagnosis and patient safety, breast ultrasound remains a critical imaging solution supporting long-term market growth.

The automated ultrasound segment generated USD 2.3 billion in 2025 and accounted for a share of 65.1%. Automated breast ultrasound technology provides comprehensive imaging through standardized scanning, enabling consistent image quality and detailed visualization of breast tissue. Reduced operator dependency and enhanced diagnostic reliability continue to support strong adoption of automated systems in clinical practice.

The hospitals segment accounted for 45.6% share in 2024 and remains the leading care setting for breast ultrasound procedures. These facilities offer access to advanced imaging equipment and integrated diagnostic services, supporting accurate detection, evaluation, and follow-up within a single care environment.

North America Breast Ultrasound Market represented 34% share in 2025. Rising disease prevalence, strong screening adoption, and continuous technology integration are driving demand across the region. Healthcare providers increasingly rely on advanced ultrasound solutions to improve diagnostic confidence and reduce interpretation variability.

Key companies operating in the Global Breast Ultrasound Market include GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Samsung Electronics Co. Ltd., Hologic, Inc., Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Delphinus Medical Technologies, Inc., CapeRay, Seno Medical Instruments Inc., Fukuda Denshi, and others. Companies in the breast ultrasound market strengthen their competitive position by investing in advanced imaging innovation, automation, and diagnostic accuracy. Many players focus on developing systems with improved resolution, workflow efficiency, and reduced operator variability. Strategic partnerships with healthcare providers and research institutions support clinical validation and market expansion. Firms also emphasize integration with digital health platforms and AI-assisted diagnostics to enhance detection capabilities. Expanding global distribution networks and offering comprehensive service and training programs help improve adoption.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of breast cancer worldwide
    • 3.2.1.2 Rising technological advancements in breast ultrasound systems
    • 3.2.1.3 Rising awareness and favourable government initiatives regarding breast cancer
    • 3.2.1.4 Increased reimbursement for breast ultrasound in the U.S.
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of the automated breast ultrasound system devices
    • 3.2.2.2 Lack of skilled or trained personnel in the developing and underdeveloped region
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration with Telemedicine
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis, 2024
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Conventional ultrasound
• 5.3 Automated ultrasound

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic Laboratories
• 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 CapeRay
• 8.2 Delphinus Medical Technologies, Inc.
• 8.3 GE Healthcare
• 8.4 Koninklijke Philips N.V.
• 8.5 Siemens Healthineers AG
• 8.6 Canon Medical Systems Corporation
• 8.7 Fukuda Denshi
• 8.8 Hologic, Inc.
• 8.9 Seno Medical Instruments Inc.
• 8.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 8.11 Samsung Electronics Co. Ltd.
• 8.12 FujiFilm Holdings Corporation